These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3416074)

  • 1. DDAVP and epinephrine-induced changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa.
    Takeuchi M; Nagura H; Kaneda T
    Blood; 1988 Sep; 72(3):850-4. PubMed ID: 3416074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exercise, DDAVP, and epinephrine on the factor VIII:C/von Willebrand factor complex in normal dogs and von Willebrand factor deficient Doberman pinscher dogs.
    Meyers KM; Wardrop KJ; Dodds WJ; Brassard J
    Thromb Res; 1990 Jan; 57(1):97-108. PubMed ID: 2105540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.
    Kaufmann JE; Oksche A; Wollheim CB; Günther G; Rosenthal W; Vischer UM
    J Clin Invest; 2000 Jul; 106(1):107-16. PubMed ID: 10880054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease.
    McCarroll DR; Ruggeri ZM; Montgomery RR
    Blood; 1984 Mar; 63(3):532-5. PubMed ID: 6607754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimeric analysis of von Willebrand factor before and after desmopressin acetate (DDAVP) administration intravenously and subcutaneously in male beagle dogs.
    Kraus KH; Turrentine MA; Johnson GS
    Am J Vet Res; 1987 Sep; 48(9):1376-9. PubMed ID: 3499101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDAVP-induced release of von Willebrand factor from endothelial cells in vitro: the effect of plasma and blood cells.
    Hashemi S; Tackaberry ES; Palmer DS; Rock G; Ganz PR
    Biochim Biophys Acta; 1990 Apr; 1052(1):63-70. PubMed ID: 2108732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma.
    Brown SA; Collins PW; Bowen DJ
    Thromb Haemost; 2002 Jun; 87(6):990-6. PubMed ID: 12083507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of desmopressin on von Willebrand factor multimers in Doberman Pinschers with type 1 von Willebrand disease.
    Callan MB; Giger U; Catalfamo JL
    Am J Vet Res; 2005 May; 66(5):861-7. PubMed ID: 15938072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.
    Mannucci PM; Lombardi R; Bader R; Vianello L; Federici AB; Solinas S; Mazzucconi MG; Mariani G
    Blood; 1985 Oct; 66(4):796-802. PubMed ID: 3876122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Deamino-8 D-arginine vasopressin decreases the production of 13-hydroxyoctadecadienoic acid by endothelial cells.
    Setty BN; Dampier CD; Stuart MJ
    Thromb Res; 1992 Sep; 67(5):545-58. PubMed ID: 1448788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?
    Brown SA; Eldridge A; Collins PW; Bowen DJ
    J Thromb Haemost; 2003 Aug; 1(8):1714-7. PubMed ID: 12911582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.
    Bykowska K; Letowska M; Sabliński J; Binder BR; Kopeć M; Lopaciuk S
    Acta Haematol Pol; 1994; 25(3):261-8. PubMed ID: 7992599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDAVP: does the drug have a direct effect on the vessel wall?
    Barnhart MI; Chen S; Lusher JM
    Thromb Res; 1983 Jul; 31(2):239-53. PubMed ID: 6415852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen.
    Ghosh S; Rao AK
    Thromb Res; 1993 Jun; 70(5):417-22. PubMed ID: 7690994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of inhibitors in acquired von Willebrand syndrome.
    Mohri H; Motomura S; Kanamori H; Matsuzaki M; Watanabe S; Maruta A; Kodama F; Okubo T
    Blood; 1998 May; 91(10):3623-9. PubMed ID: 9572997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels.
    Vischer UM; Ingerslev J; Wollheim CB; Mestries JC; Tsakiris DA; Haefeli WE; Kruithof EK
    Thromb Haemost; 1997 Feb; 77(2):387-93. PubMed ID: 9157601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor.
    Cattaneo M; Moia M; Delle Valle P; Castellana P; Mannucci PM
    Blood; 1989 Nov; 74(6):1972-5. PubMed ID: 2508791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the spleen in regulating the plasma levels of factor VIII--von Willebrand's factor after DDAVP.
    Garcia VV; Coppola R; Mannucci PM
    Blood; 1982 Dec; 60(6):1402-6. PubMed ID: 6814552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP).
    Kaufmann JE; Vischer UM
    J Thromb Haemost; 2003 Apr; 1(4):682-9. PubMed ID: 12871401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.